UK Stocks That May Be Trading Below Their Estimated Value

The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and global economic uncertainties. As the market navigates these turbulent times, investors may find opportunities in stocks that appear undervalued relative to their intrinsic value, potentially offering long-term growth prospects despite current volatility.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

Name	Current Price	Fair Value (Est)	Discount (Est)
Yü Group (AIM:YU.)	£17.95	£33.48	46.4%
Victorian Plumbing Group (AIM:VIC)	£0.757	£1.39	45.5%
Living REIT (LSE:LIVE)	£0.785	£1.56	49.7%
Kistos Holdings (AIM:KIST)	£2.75	£5.37	48.8%
GB Group (LSE:GBG)	£2.07	£3.76	44.9%
Fevara (LSE:FVA)	£1.47	£2.86	48.7%
Eurocell (LSE:ECEL)	£1.15	£2.20	47.7%
Entain (LSE:ENT)	£5.48	£10.84	49.4%
Burberry Group (LSE:BRBY)	£10.375	£19.71	47.4%
Accsys Technologies (AIM:AXS)	£0.746	£1.46	48.7%

Click here to see the full list of 40 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Here we highlight a subset of our preferred stocks from the screener.

AstraZeneca (LSE:AZN)

Overview: AstraZeneca PLC is a biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of prescription medicines, with a market cap of approximately £196.79 billion.

Operations: AstraZeneca's revenue is primarily derived from its Pharmaceuticals segment, which generated $60.44 billion.

Estimated Discount To Fair Value: 44.3%

AstraZeneca appears undervalued based on cash flows, trading at £126.88 against an estimated future cash flow value of £227.97, indicating a potential mispricing by the market. Despite high debt levels, AstraZeneca's revenue and earnings are forecast to grow faster than the UK market averages. Recent strategic alliances and product developments could enhance its growth prospects, although the company faces challenges in achieving significant profit growth compared to previous years.

• In light of our recent growth report, it seems possible that AstraZeneca's financial performance will exceed current levels.
• Dive into the specifics of AstraZeneca here with our thorough financial health report.

BAE Systems (LSE:BA.)

Overview: BAE Systems plc offers defense, aerospace, and security solutions across the United States, the United Kingdom, the Middle East, Australia, Saudi Arabia, Europe, and internationally with a market cap of £55.66 billion.

Operations: The company's revenue segments include Air (£7.37 billion), Maritime (£6.58 billion), Electronic Systems (£7.51 billion), Cyber & Intelligence (£2.40 billion), and Platforms & Services (£5.02 billion).

Estimated Discount To Fair Value: 21%

BAE Systems is trading at £19.65, below its estimated future cash flow value of £24.86, suggesting it may be undervalued based on cash flows. The company has secured multiple defense contracts recently, including a $535 million deal for U.S. Army artillery systems and a contract with Boeing for advanced fighter jet systems. While earnings are forecast to grow by 11.81% annually, the growth rate is not considered significant but remains above UK market averages.

• Insights from our recent growth report point to a promising forecast for BAE Systems' business outlook.
• Click here and access our complete balance sheet health report to understand the dynamics of BAE Systems.

Babcock International Group (LSE:BAB)

Overview: Babcock International Group PLC is involved in the design, development, manufacture, and integration of specialist systems for aerospace, defense, and security sectors across various regions including the UK and internationally, with a market cap of £5.56 billion.

Operations: The company's revenue segments comprise £1.08 billion from Land, £1.59 billion from Marine, £2.07 billion from Nuclear, and £431.40 million from Aviation sectors.

Estimated Discount To Fair Value: 11.5%

Babcock International Group is trading at £11.34, slightly below its estimated future cash flow value of £12.81, reflecting potential undervaluation based on cash flows. Despite a decrease in net income to £211.2 million from the previous year, earnings are projected to grow by 18.8% annually, outpacing the UK market average of 11.4%. Recent initiatives include a £248.72 million fixed income offering and a share buyback program worth up to £200 million.

• Upon reviewing our latest growth report, Babcock International Group's projected financial performance appears quite optimistic.
• Navigate through the intricacies of Babcock International Group with our comprehensive financial health report here.

Where To Now?

• Investigate our full lineup of 40 Undervalued UK Stocks Based On Cash Flows right here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com